HIV drug trial halted early: what happened?
NCT ID NCT06061081
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tested a new experimental drug, VH3739937, in 21 adults with HIV who had never taken HIV medications before. The goal was to see how well the drug lowered the virus level in the blood over a short period. The trial was stopped early by the sponsor, and results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Bakersfield, California, 93301, United States
-
GSK Investigational Site
Miami, Florida, 33136, United States
-
GSK Investigational Site
Dallas, Texas, 75246, United States
-
GSK Investigational Site
Buenos Aires, C1181ACH, Argentina
-
GSK Investigational Site
Rosario, 2000, Argentina
-
GSK Investigational Site
Athens, 12462, Greece
-
GSK Investigational Site
Brescia, 25123, Italy
-
GSK Investigational Site
Genova, 16132, Italy
-
GSK Investigational Site
Milan, 20142, Italy
-
GSK Investigational Site
Roma, 00133, Italy
-
GSK Investigational Site
Warsaw, 01-201, Poland
-
GSK Investigational Site
A Coruña, 15006, Spain
-
GSK Investigational Site
Alicante, 03010, Spain
-
GSK Investigational Site
Granada, 18014, Spain
-
GSK Investigational Site
Jerez de la Frontera, 11407, Spain
-
GSK Investigational Site
Madrid, 28006, Spain
-
GSK Investigational Site
Madrid, 28222, Spain
-
GSK Investigational Site
Vitoria-Gasteiz, 1009, Spain
Conditions
Explore the condition pages connected to this study.